Tradestie Institutional Equity Comparison Engine

EBS vs ANTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ANTX Overall Edge

ANTX Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AN2 Therapeutics, Inc. Common Stock (ANTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while EBS counters with relative strength in Valuation. Fundamentally, EBS trades at 19.3x Forward P/E with 5.8% operating margin (-52.4% YoY revenue) versus ANTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EBS sits in BREAKDOWN (5th %ile IV; Dealer Gamma Walls on Pro) against ANTX sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EBS
EBS 19.3x vs ANTX N/M Fwd P/E
Growth & Margin Winner ANTX
Op Margin 5.8% vs 0.0% ยท YoY -52.4% vs +0.0%
Momentum & Technical Winner ANTX
1Y -49.1% vs +366.1% ยท 52W Pos 8% vs 68%
Options & Structure Winner ANTX
BREAKDOWN (5th %ile IV) vs CONSOLIDATION (22nd %ile IV)
EBS NYSE
Emergent Biosolutions, Inc.
Pharmaceutical Preparations
$5.15
-6.36% 1D
Market Cap $282.8M
1M Return -16.94%
1Y Return -49.11%
Forward P/E 19.3x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 51.0 Flow 67.0 Mom 59.0
ANTX NASDAQ
AN2 Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$5.22
+5.45% 1D
Market Cap $190.1M
1M Return +45.0%
1Y Return +366.07%
Forward P/E N/M
Unified AI Score
37.2 / 100 SELL
Tech 15.0 Fund 39.0 Flow 69.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EBS -49.11% ANTX +366.07% Spread: +415.18 pp (ANTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EBS TTM Op. Margin: 5.8% ANTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EBS vs ANTX. Trailing 12-month operating profitability (EBS 5.8% vs ANTX 0.0%) and valuation multiples (EBS 19.3x vs ANTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EBS (6) vs ANTX (4)
Institutional Metric EBS ANTX Criterion Row Winner
Market Capitalization Scale $282.8M $190.1M Larger Scale EBS
Trailing P/E Ratio Valuation 19.3x N/M Lower Multiple EBS
Forward P/E Ratio Valuation 19.3x N/M Lower Multiple EBS
Revenue Growth (YoY) Growth -52.4% +0.0% Higher Growth ANTX
Operating Margin (TTM) Profitability 5.8% 0.0% Higher Margin EBS
Net Profit Margin Profitability -40.2% 0.0% Higher Margin ANTX
Return on Equity (ROE) Capital Efficiency -58.2% -51.3% Higher ROE ANTX
52-Week Range Position Momentum 8% ($4โ€“$14) 68% ($1โ€“$7) Stronger Trend ANTX
Beta / 30D Volatility Risk Regime 0.90ฮฒ ยท 54% Vol 0.75ฮฒ ยท 98% Vol Lower Realized Risk EBS
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 37.2 / 100 (SELL) Higher Composite EBS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EBS vs ANTX Buy Guide
EBS BREAKDOWN
33d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live EBS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANTX CONSOLIDATION
177d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live ANTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EBS nor ANTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.